// App-Quantinova.ai

4549 : Association between neutrophil-to-eosinophil ratio (NER) and efficacy outcomes in the JAVELIN Renal 101 study.

Researchers

Presenter

  • Matthew D. Tucker

Principal Investigators

  • Martin H Voss

  • Toni K. Choueiri

  • Mehmet Asim Bilen

  • Marc-Oliver Grimm

  • Paul D. Nathan

  • Christian K. Kollmannsberger

  • Yoshihiko Tomita

  • Bo Huang

  • Despina Thomaidou

  • Mariangela Mariani

  • Alessandra Di Pietro

  • Brian I. Rini

Medical Centers

  • Vanderbilt University Medical Center, Nashville, TN

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology, Boston, MA

  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

  • Department of Urology, Universitaetsklinikum Jena, Jena, Germany

  • Mount Vernon Cancer Centre, Northwood, United Kingdom

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Canada.

  • Nigata University Graduate School of Medical and Dental Sciences, Japan

  • Pfizer, Groton, CT

  • Pfizer Hellas, Athens, Greece

  • Pfizer Inc, Milan, Italy

  • Vanderbilt-Ingram Cancer Center, Nashville, TN

Locations

  • United States

  • Germany

  • United Kingdom

  • Canada

  • Japan

  • Greece

  • Italy

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Sunitinib

  • Inlyta

  • Avelumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT02684006

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved